Jin Liang, Zhao Yuan, Qian Xiaojing, Pan Lingyun, Chen Long, Feng Jingwen, Liu Xinhua, Lu Xiaotong
Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China.
Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Front Pharmacol. 2024 Sep 16;15:1382760. doi: 10.3389/fphar.2024.1382760. eCollection 2024.
Postoperative Intestinal Adhesions (PIAs) remain a significant complication of abdominal surgery that can cause pain, infertility, and a potentially lethal bowel obstruction. Kangnian (KN) decoction, a Traditional Chinese Medicine prescription, has been shown to be effective in treating PIAs. Nevertheless, its underlying mechanisms remain unclear.
This study aims to explore the therapeutic effects of KN decoction in a PIA rat model, as well as its potential mechanisms via metabolomics and proteomics analyses.
60 rats were randomly assigned to six groups: Normal Control (NC), PIA model, Dexamethasone, KN-Low, KN-Medium, and KN-High. The PIA model was created by abdominal surgery under anesthesia. Pathological damage was evaluated through H&E staining and adhesion grading of affected tissues. The levels of serum cytokines (IL-1β, IL-6, TNF-α, and TGF-1), Connective Tissue Growth Factor (CTGF), and Motilin (MTL) in adherent intestinal tissues were detected using ELISA kits. Untargeted metabolomics was used to investigate potential metabolic pathways of the KN decoction intervention in intestinal adhesions and to screen for differential biomarkers. The label-free quantitative proteomics technique was employed to detect Differentially Expressed Proteins and for biological function and pathway enrichment analyses.
In PIA rats, KN decoction significantly improved the pathological injury associated with intestinal adhesions and effectively regulated the blood inflammation indicators. Furthermore, KN presented a favorable anti-fibrotic and protective effect against abdominal adhesions, effectively modifying gastrointestinal motility disorders in PIA rats. We identified 58 variables as potential biomarkers and discovered seven main pathological pathways that may be associated with PIAs. Proteomics analysis revealed 75 DEPs that were primarily involved in Valine, leucine, and isoleucine degradation, the MAPK signaling pathway, and retrograde endocannabinoid signaling.
This study proved that KN reduces intestinal mucosal injury, downregulates inflammatory factors, and alleviates intestinal adhesions, thus protecting the intestinal barrier function in PIA rats. The combination of proteomics and metabolomics provided a feasible approach for unraveling the therapeutic mechanism of KN decoction in PIAs.
术后肠粘连(PIAs)仍然是腹部手术的一个重要并发症,可导致疼痛、不孕以及潜在致命的肠梗阻。康年(KN)汤是一种中药方剂,已被证明对治疗PIAs有效。然而,其潜在机制仍不清楚。
本研究旨在探讨KN汤对PIA大鼠模型的治疗作用及其通过代谢组学和蛋白质组学分析的潜在机制。
60只大鼠随机分为六组:正常对照组(NC)、PIA模型组、地塞米松组、KN低剂量组、KN中剂量组和KN高剂量组。PIA模型通过麻醉下的腹部手术建立。通过苏木精-伊红(H&E)染色和对受影响组织的粘连分级来评估病理损伤。使用酶联免疫吸附测定(ELISA)试剂盒检测粘连肠组织中血清细胞因子(白细胞介素-1β、白细胞介素-6、肿瘤坏死因子-α和转化生长因子-1)、结缔组织生长因子(CTGF)和胃动素(MTL)的水平。采用非靶向代谢组学研究KN汤干预肠粘连的潜在代谢途径并筛选差异生物标志物。采用无标记定量蛋白质组学技术检测差异表达蛋白并进行生物学功能和通路富集分析。
在PIA大鼠中,KN汤显著改善了与肠粘连相关的病理损伤,并有效调节了血液炎症指标。此外,KN对腹部粘连呈现出良好的抗纤维化和保护作用,有效改善了PIA大鼠的胃肠动力障碍。我们确定了58个变量作为潜在生物标志物,并发现了7条可能与PIAs相关的主要病理途径。蛋白质组学分析揭示了75个差异表达蛋白,主要参与缬氨酸、亮氨酸和异亮氨酸降解、丝裂原活化蛋白激酶(MAPK)信号通路和逆行内源性大麻素信号传导。
本研究证明KN可减轻肠黏膜损伤,下调炎症因子,减轻肠粘连,从而保护PIA大鼠的肠屏障功能。蛋白质组学和代谢组学的结合为阐明KN汤治疗PIAs的机制提供了一种可行的方法。